Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/2/25 18:45 | 4/1/25 | AMPH | Health | Drug | Pharmaceutical Preparations | Petersen Floyd F. | CA | D | 11 | S.d | -479 | 43.52 | 0 | -11 | 81 | D | ||||||||||||||||
3/6/25 17:00 | 3/4/25 | AMPH | Health | Drug | Pharmaceutical Preparations | Peters William J | CA | DO | CFO,EVP, | 5 | S.d | -1,948 | 44.60 | 0 | -44 | 109 | D | |||||||||||||||
12/16/24 17:22 | 12/12/24 | AMPH | Health | Drug | Pharmaceutical Preparations | Zhou Rong | CA | O | SENIOR E | 5 | S.dm | -1,810 | 49.29 | 0 | -37 | 223 | D | |||||||||||||||
12/11/24 20:28 | 12/9/24 | AMPH | Health | Drug | Pharmaceutical Preparations | Prins Richard K | CA | D | 3 | S.d | -1,418 | 44.18 | 0 | -32 | 34 | D | ||||||||||||||||
11/8/24 19:02 | 11/6/24 | AMPH | Health | Drug | Pharmaceutical Preparations | Liawatidewi Yakob | CA | DO | EVP Corp | 1 | S.d | -271 | 52.05 | 0 | -5 | 77 | D | |||||||||||||||
3/6/24 17:57 | 3/5/24 | AMPH | Health | Drug | Pharmaceutical Preparations | Zasloff Michael A | CA | D | 1 | S | -590 | 47.18 | 0 | -13 | 21 | D | ||||||||||||||||
1/11/24 16:37 | 1/10/24 | AMPH | Health | Drug | Pharmaceutical Preparations | Luo Mary Z. | CA | DOT | COO,Chie | 2 | S.m | -19,970 | 56.87 | 0 | -351 | 10,147 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |